An international multidisciplinary consensus statement on pediatric metabolic dysfunction-associated fatty liver disease

Title: An international multidisciplinary consensus statement on pediatric metabolic dysfunction-associated fatty liver disease
Edition: Original
Classification: Experts consensus
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Clinicians, nurses and technicians engaged in pediatric liver disease in hospitals
Evidence classification method: Grading of recommendations assessment, development and evaluation
Development unit: panel of International experts and CHESS-MAFLD collaboration
Registration time: 2023-11-20
Registration number: PREPARE-2023CN919
Purpose of the guideline: Management and treatments provide a framework for the development of appropriate guidance in pediatric patients with metabolic (dysfunction)-associated fatty liver disease